4
Changes in Ownership
Inmune Bio, Inc. Filed Acc 0001213900-25-112239
Options or other derivatives
- Chief Executive Officer acquired 1,478,000 shares (grant or award)
- Chief Executive Officer returned 1,478,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Moss David J Chief Executive Officer | 2025-11-18 | Returned to the company · Stock Option (right to buy) | −400,000 | 0 | D: show line 1 in the form | |||||
| Moss David J Chief Executive Officer | 2025-11-18 | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | D: show line 2 in the form | |||||
| Moss David J Chief Executive Officer | 2025-11-18 | Returned to the company · Stock Option (right to buy) | −59,337 | 0 | D: show line 3 in the form | |||||
| Moss David J Chief Executive Officer | 2025-11-18 | Grant or award · Stock Option (right to buy) | +59,337 | 59,337 | D: show line 4 in the form | |||||
| Moss David J Chief Executive Officer | 2025-11-18 | Returned to the company · Stock Option (right to buy) | −275,000 | 0 | D: show line 5 in the form | |||||
| Moss David J Chief Executive Officer | 2025-11-18 | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | D: show line 6 in the form | |||||
| Moss David J Chief Executive Officer | 2025-11-18 | Returned to the company · Stock Option (right to buy) | −70,663 | 0 | D: show line 7 in the form | |||||
| Moss David J Chief Executive Officer | 2025-11-18 | Grant or award · Stock Option (right to buy) | +70,663 | 70,663 | D: show line 8 in the form |
Loading xslF345X05/ownership.xml…